ARYx Therapeutics, Inc. (ARYX)

Other OTC - Other OTC Preço Adiado. Moeda em USD.

Adicionar à lista

0,0000

(0,00%)

No fechamento: 01:20PM EDT

Principais Titulares

Lista de insiders

Transações de insiders

Câmbio em USD

Compras de insiders nos últimos 6 meses	Ações	Trans
Compras	0	0
Vendas	N/A	0
Ações Líquidas Compradas (Vendidas)	0	0
Total de Ações de insiders	N/A	N/A
& Ações Líquidas Compradas (Vendidas)	N/A	N/A

Compras institucionais líquidas do trimestre anterior ao último trimestre	Ações
Ações Líquidas Compradas (Vendidas)	N/A
% Variação em Ações Institucionais	N/A

Transações de insiders - Últimos Dois Anos

Insider	Transação	Tipo	Valor	Data	Ações
BASKETT FOREST Beneficial Owner of more than 10% of a Class of Security	Sale at price 0.07 per share.	Indireto	326.257	10 de mar. de 2011	4.469.270
KERINS PATRICK JOHN Beneficial Owner of more than 10% of a Class of Security	Sale at price 0.07 per share.	Indireto	326.257	10 de mar. de 2011	4.469.270
KOLLURI KRISHNA KITTU Beneficial Owner of more than 10% of a Class of Security	Sale at price 0.07 per share.	Indireto	326.257	10 de mar. de 2011	4.469.270
DRANT RYAN D Beneficial Owner of more than 10% of a Class of Security	Sale at price 0.07 per share.	Indireto	326.257	10 de mar. de 2011	4.469.270
GROWTH EQUITY OPPORTUNITIES FUND L L C Beneficial Owner of more than 10% of a Class of Security	Sale at price 0.07 per share.	Indireto	326.257	10 de mar. de 2011	4.469.270
NAGLER DAVID Officer	Stock Gift at price 0.00 per share.	Direto	0	21 de dez. de 2009	1.250
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 5.42 per share.	Indireto	10.848.000	22 de mai. de 2009	2.000.000
SIMON NICHOLAS J III Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.20 per share.	Indireto	3.932.962	14 de nov. de 2008	1.787.710
EVNIN LUKE BASIL Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.20 per share.	Indireto	3.932.962	14 de nov. de 2008	1.787.710
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.35 per share.	Indireto	2.854.428	14 de nov. de 2008	1.214.650
MPM BIOVENTURES III QP L P Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.20 per share.	Indireto	3.932.962	14 de nov. de 2008	1.787.710
ADELMAN ROBERT J Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.35 per share.	Indireto	2.854.428	14 de nov. de 2008	1.214.650
SIMON NICHOLAS J III Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.89 per share.	Indireto	2.367.000	13 de nov. de 2007	300.000
SIMON NICHOLAS J III Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.00 per share.	Indireto	0	13 de nov. de 2007	3.281.270
GODDARD PAUL Chief Executive Officer	Conversion of Exercise of derivative security at price 0.00 per share.	Indireto	0	13 de nov. de 2007	3.021
EVNIN LUKE BASIL Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.89 per share.	Indireto	2.367.000	13 de nov. de 2007	300.000
EVNIN LUKE BASIL Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.00 per share.	Indireto	0	13 de nov. de 2007	3.276.868
ORBIMED ADVISORS, L.L.C. Unknown	Purchase at price 7.89 per share.	Indireto	2.367.000	13 de nov. de 2007	300.000
ORBIMED ADVISORS, L.L.C. Unknown	Conversion of Exercise of derivative security at price 0.00 per share.	Indireto	0	13 de nov. de 2007	1.825.490
MPM BIOVENTURES III QP L P Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.89 per share.	Indireto	2.367.000	13 de nov. de 2007	300.000
MPM BIOVENTURES III QP L P Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.00 per share.	Indireto	0	13 de nov. de 2007	3.276.868
ADELMAN ROBERT J Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.89 per share.	Indireto	2.367.000	13 de nov. de 2007	300.000
ADELMAN ROBERT J Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.00 per share.	Indireto	0	13 de nov. de 2007	1.825.493
DRUZGALA PASCAL Officer	Conversion of Exercise of derivative security at price 0.00 per share.	Direto	0	13 de nov. de 2007	1.122
MILNER PETER G Officer and Director	Conversion of Exercise of derivative security at price 0.00 per share.	Indireto	0	13 de nov. de 2007	47.739
NOMURA PHASE4 VENTURES LTD Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.00 per share.	Indireto	0	13 de nov. de 2007	2.447.730

BOVESPA128.508,67+1.386,42(+1,09%)

MERVAL38.390,84+233,89(+0,61%)

MXX57.135,26+458,21(+0,81%)

PETROLEO CRU77,99-0,96(-1,22%)

OURO2.310,10+0,50(+0,02%)

Bitcoin USD63.620,62+1.828,40(+2,96%)

ARYx Therapeutics, Inc. (ARYX)

Transações de insiders

Transações de insiders - Últimos Dois Anos

BOVESPA
128.508,67
+1.386,42(+1,09%)

MERVAL
38.390,84
+233,89(+0,61%)

MXX
57.135,26
+458,21(+0,81%)

PETROLEO CRU
77,99
-0,96(-1,22%)

OURO
2.310,10
+0,50(+0,02%)

Bitcoin USD
63.620,62
+1.828,40(+2,96%)